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Finding genetic variants that contribute to phenotypic variation is one of the main challenges of modern
genetics. We used an outbred population of rats (Heterogeneous Stock, HS) in a combined sequence-based
and genetic mapping analysis to identify sequence variants and genes contributing to complex traits of
biomedical relevance. Here we describe the sequences of the eight inbred progenitors of the HS and the
variants that segregate between them. We report the genotyping of 1,407 HS rats, and the collection from
2,006 rats of 195 phenotypic measures that are relevant to models of anxiety, type 2 diabetes, hypertension
and osteoporosis. We make available haplotype dosages for the 1,407 genotyped rats, since genetic
mapping in the HS is best carried out by reconstructing each HS chromosome as a mosaic of the progenitor
genomes. Finally, we have deposited an R object that makes it easy to incorporate our sequence data into
any genetic study of HS rats. Our genetic data are available for both Rnor3.4 and Rnor5.0 rat assemblies.
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Background & Summary
Uncovering genetic variants that contribute to variation in complex traits is expected to provide insights
into the biology of these traits. Genetic mapping in humans and animal models has identiﬁed many
regions of the genome that contribute to variation in quantitative traits (Quantitative Trait Loci, QTL),
but has been less successful at revealing causal variants1–3. Finding causal variants would allow a
mechanistic understanding of how phenotypic variation arises, and aid with the identiﬁcation of
relevant genes.
In a study published in Nature Genetics4, we investigated the use of sequence information to ﬁnd the
sequence variants and genes responsible for phenotypic variation. We used an outbred population of rats
descended from eight inbred progenitors (ACI/N, BN/SsN - a sub-strain of the reference strain BN, BUF/
N, F344/N, M520/N, MR/N, WKY/N and WN/N) through more than 60 generations of outbreeding5,6
(Figure 1). The Heterogeneous Stock (HS) was chosen for its potential for high-resolution mapping.
Because a large number of recombination events have accumulated over the generations, each HS rat is a
ﬁne-grained mosaic of the founder genomes.
The known ancestry of the HS offers an additional advantage: by sequencing the eight progenitors
only, it is possible to evaluate whether one or more causal variant(s) segregate(s) at each QTL
mapped in the outbred rats, and when a single variant was likely to account for the QTL, sequence
information allowed identifying the causal variant and/or gene at about 10% of the QTLs. Our results
provided insights on models of anxiety, type 2 diabetes, osteoporosis and the cardiovascular function
(Table 1).
We collected 195 phenotypes of biomedical relevance (Supplementary Table 1) on 2,006 outbred rats,
and genotyped both 1,407 of the outbred rats and the eight progenitors (Figure 1) using a custom
Affymetrix array (see supplementary note in ref. 4 for more information on the array). Because the
outbred rats are descended from more than two progenitors, genetic mapping in the HS is best carried
out by testing for association between the phenotype and the progenitor haplotypes4,7 rather than the
genotypes. Therefore, we reconstructed each HS rat chromosome as a mosaic of the founder haplotypes
using the HAPPY software7. We also sequenced the eight progenitors of the population (Figure 1) with
SOLiD technology in order to investigate causal variants using a statistical method called merge analysis8.
Figure 2 shows how the HS genotypes and progenitor sequences can be combined for different analyses.
We submitted both raw data (phenotypes and genotypes of the outbred rats, sequences of the
progenitors) as well as derived data (haplotype dosages for the outbred rats, sequence variants calls
formatted for merge analysis) to ArrayExpress (Data Citation 1) and ﬁgshare (Data Citation 2). The raw
data are available for both the previous Rnor3.4 and current Rnor5.0 rat assemblies while the derived data
are available for the current assembly only.
The data collected on the outbred rats are speciﬁc to the animals used in this study, but they may be
used for meta-analysis with data collected on other HS rats. The sequences of the progenitors and the
resulting variant calls will be invaluable for those investigators that have phenotyped and genotyped other
HS rats (or plan to do so)9–11, and in fact for any genetic study of a cross descended from some of the HS
progenitors. Finally, combined with other rat sequences12, our data may also support population genetics
studies.
Figure 1. Experimental design and data collected. The Heterogeneous Stock is descended from eight
inbred progenitors through more than 60 generations of outbreeding. As a result, each HS rat chromosome
is a ﬁne-grained mosaic of the founder genomes. The outbred rats included in this study were from
generations 62 to 70 and were bred at the University of Barcelona (UAB). NIH: National Institute of Health;
NU: Northwestern University (see methods). The data collected are shown on the left hand side of the
ﬁgure, with the number of observation for each indicated in brackets.
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Methods
Animals
The rat Heterogeneous Stock was established in the 1980s at NIH (Dr Carl Hansen) and went through 50
generations of rotational breeding there. A colony was established at Northwestern University, Chicago,
IL (Dr Eva Redei) where the Stock went through another 2 generations before 40 breeding pairs were sent
to the University Autonomous of Barcelona (UAB, Dr Alberto Fernandez-Teruel) where the rats used for
Phenotype Disease model Number of
measures
Age (weeks)
Coat colour 1 7
Wound healing 1 7 and 17
Fear related behaviours Anxiety 48 8 to 10
Glucose tolerance Type II diabetes 6 11
Cardiovascular function Hypertension 2 12
Basal hematology 32 13
Basal immunology 34 13
Immunization with myelin oligodendrocyte protein 13
Serum biochemistry 15 17
Arterial elastic lamina ruptures 6 17
Renal agenesis 1 17
Body weight Obesity 6 8, 9, 11, 13, 14, and 17
Bone mass and strength Osteoporosis 43 17
Table 1. Phenotyping pipeline.
Figure 2. Generation and use of derived genetic data. (a) This ﬂow chart shows how the derived genetic
data (haplotypes dosages, merge factors, imputed variants) were obtained from the raw data. The name of
the ﬁle corresponding to each data item is shown, and coloured in green when it was submitted to
ArrayExpress (Data Citation 1), and blue when it was submitted to ﬁgshare (Data Citation 2). (b) Data to
combine for genetic mapping and merge analysis.
www.nature.com/sdata/
SCIENTIFIC DATA | 1:140011 | DOI: 10.1038/sdata.2014.11 3
this study were bred using a rotational breeding scheme (further details are available in ref. 6). The Stock
went through another 9 generations at UAB before the ﬁrst rats were genotyped and phenotyped. The
scheme used to produce HS rats for phenotyping while maintain the colony is illustrated in Figure 1. At
each generation, one male and one female from each sibship were kept to breed the next generation while
a maximum of 8 of the remaining siblings were included in the study, keeping half of each sex whenever
possible. Animals were housed in pairs (males) or groups of three (females), in macrolon cages
(50 × 25 × 14 cm), and maintained with food (standard diet A04 by Panlab L.S Barcelona, Spain and tap
water available ad lib, under conditions of controlled temperature (22± 2 °C; relative humidity 50–70%)
and a 12-h light-dark cycle (lights on at 08:00 h). Rats from eight generations are represented in the
dataset, phenotyped over a period of three years.
All procedures were carried out in accordance with Spanish legislation on the Protection of Animals
Used for Experimental and Other Scientiﬁc Purposes and the European Community's Council Directive
(86/609/EEC) on this subject. The experimental protocol was approved by the Autonomous University of
Barcelona ethics committee (permit CEEAH 697).
Phenotyping
The phenotyping pipeline is presented in Table 1. The phenotypes were uploaded to a database
(Integrated Genotyping System13) as they were collected. A description of all the measures (phenotypes
and covariates) collected is given in Supplementary Table 1. All the below phenotyping protocols are a
more detailed description of the methods published in the Nature Genetics paper4.
Coat colour
The following code is used to describe coat colour: DB (dark brown), DBsp (dark brown, spotted), LB
(light brown), LBsp (light brown, spotted), W (white).
Fear related behaviours
All testing was performed between 9 h and 19 h. For each behavioural test males and females, as well as
families, were tested in a counterbalanced manner across the time of the day and across days. Behavioural
testing is included in Whole organism phenotyping in Supplementary Table 2.
Elevated zero maze: The ﬁrst behavioural test was the elevated zero maze, which is used to evaluate
unlearned anxiety-like behaviour in rodents14–17. The maze, similar to that described by Shepherd et al.,
comprised an annular platform (105 cm diameter; 10 cm width) made of black plywood and elevated to
65 cm above the ground level. It had two open sections (quadrants) and two enclosed ones (with walls 40
cm height). The apparatus was situated in a black testing room, dimly illuminated with red ﬂuorescent
light (approximately 50 lux at the level of the apparatus). The rats were individually placed in an enclosed
section facing the wall and the behaviour was videotaped and measured outside the testing room15. The
apparatus was cleaned with 20% ethanol and dried with paper towel between consecutive rats. The
measures collected in the zero maze are: latency to enter an open section, time spent in the open sections,
number of entries in the open sections, number of times the rat went from an open to a closed section or
vice versa, number of head dips, and number of stretched attend postures.
Automated novel-cage ‘open ﬁeld-like’ activity: Exploration of a novel, open ﬁeld-like environment
(i.e., the ‘novel-cage’ activity test), has been traditionally considered as related to fearfulness (i.e., the
lower exploration, the higher the level of fearfulness), a contention which is also supported from previous
work showing associations between activity during 5 minutes in the novel cage and typical anxiety
responses in the light-dark test and the elevated zero-maze test15–17. If longer testing intervals are used,
the test reﬂects general activity (i.e., activity with lesser inﬂuence from novelty) in both mice and rats. The
apparatus (Panlab, Barcelona, Spain) consisted of a horizontal surface (50 × 50 cm) provided with photo
beams that detect movement and measure it automatically, loading the data in a computer. The rats were
placed in transparent Plexiglas cages (40 × 40 × 40 cm) facing the wall, in a white ﬂuorescent (60 w)
illuminated chamber15, and their movements recorded for 30 min. There were 4 identical activity cages
separated by an opaque plate (to avoid vision among rats from different cages), thus 4 rats were tested
simultaneously and individually. Each activity cage was cleaned with 20% ethanol and dried with paper
towel between consecutive rats. Activity level during the ﬁrst 5 min indicates (open ﬁeld-like) response to
novelty while activity in the last 5-min intervals is indicative of habituated exploration15,16. The measures
collected in the novel cage are: number of boli, distance travelled and number of rearings (upper beam
breaks) during different intervals.
Two-way active avoidance acquisition and context-conditioned fear in the shuttlebox: The
acquisition of two-way active avoidance in a shuttlebox is an aversive learning task and a well-validated
measure of conditioned anxiety, which is known to be mediated by a ‘passive avoidance/active avoidance’
conﬂict18. Context-conditioned freezing, indicating conditioned fear, can be measured during the initial
inter-trial intervals of the ﬁrst few trials of the shuttlebox avoidance task (i.e., before the ﬁrst avoidance
response17). Two-way active avoidance sessions were performed in three identical shuttleboxes (Letica
Instr., Panlab, Barcelona), each one placed in independent sound-attenuating boxes constructed
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of plywood. A dim and diffuse illumination was provided by a ﬂuorescent bulb placed behind the opaque
wall of the shuttle boxes, which gave approximately 50-lux intensity inside each of the two compartments
of the shuttle boxes. The experimental room was kept dark. The shuttleboxes consisted of two equally
sized compartments (25 × 25 cm, 28 cm) connected by an opening (8 × 10 cm). Rats were allowed a 4-min
period of familiarization to the box. Immediately after that period, a 40-trial session/rat was administered,
each trial consisting of a 10-s CS (conditioned stimulus; 2400 Hz, 63-dB tone plus a 7-W small light)
followed after termination by a 20-s US (unconditioned stimulus; scrambled 0.7 mA foot shock) delivered
through the grid ﬂoor. Each shuttlebox was carefully cleaned with 96% ethanol and dried with paper
towel between consecutive rats. Crossings to the other compartment during the CS (avoidances) or US
(escapes) switched off the stimuli and were followed by a 60-s inter-trial interval. Context-conditioned
freezing (i.e., classically-conditioned fear) was measured by two trained observers as the time a rat spent
completely motionless except for breathing movements during the 60-min inter-trial intervals of the ﬁrst
5 training trials 6,15–17. The measures collected in the shuttlebox are: number of avoidances, latency to
avoid, number of crossings from one compartment to the other during the habituation period, number of
crossings between the trials, number of freezings and time spent freezing.
Intraperitoneal Glucose Tolerance Test (IPGTT)
Food was removed in the morning and tests were carried out between 11am and 12 noon. Conscious rats
in the post absorptive state were injected intraperitoneally with a solution of glucose (Sigma D9559,
2 g/kg body weight). Blood samples were collected by tail tipping (o1 mm of the end of the tail) in
unrestrained rats. Blood glucose was read before glucose injection and 30, 60 and 120 min afterwards.
Blood glucose concentration was determined using a glucose meter (Accucheck, Roche Diagnostics,
Welwyn Garden City, UK). Cumulative glycemia (AUC_G) was calculated as the increment of the values
of plasma glucose during the IPGTT. Incremental plasma glucose values above baseline integrated over
120 min, after an injection of glucose, were used to calculate the index of glucose tolerance (DeltaG).
IPGTT is included in Whole organism phenotyping in Supplementary Table 2.
Blood pressure
Systolic blood pressure was measured by tail plethysmography in conscious, restrained animals as
previously described19,20. In short, the rats were pre-warmed for 15 min at 30 °C for tail artery
vasodilation. Warming was carried out using a ventilated polystyrene box and an overhead light source.
Rats were then wrapped in a cloth for restraint, with no prior training, and an inﬂatable cuff placed on
their tail along with a piezoceramic transducer (Hartmann & Braun type 2). Pulse detection was
visualised as a function of pressure and displayed using Microsoft Windows compatible software. 6–8
pressure readings were taken for each rat on a single day, and averaged. Blood pressure measurement is
included in Whole organism phenotyping in Supplementary Table 2.
Basal hematology
A full blood count was used to characterise haematological parameters. Rats were anaesthetized with
isoﬂuorane (O2 ﬂow of 2 L/min with 3–5% isoﬂuorane) and placed in ventral position. While holding tail
at 135° angle, a cut, 3–5 cm from the tip of the tail, was made across the ventral side with a scalpel. Blood
(300 μl/sample) was collected from the lateral tail vein of anesthetized rats into a tube pre-treated with the
anticoagulant EDTA-2K (Sangüesa) and inverted 10 times. Blood was collected immediately after the rats
were injected with emulsiﬁed myelin oligodendrocyte glycoprotein (MOG, used to induce experimental
autoimmune encephalomyelitis—see below), which therefore will not have affected basal hematology.
The blood was stored at 4 °C for up to 12 h until analysed. The samples are identiﬁed as
blood_basal_hematology in Supplementary Table 3.
Full blood count measures were acquired by an automatic hemocytometer (ADVIA 120 Hematology
analyzer from Bayer, Siemens Diagnostics). This assay is identiﬁed by the method Blood count in
Supplementary Table 2.
Basal immunology
Fluorescence-activated cell sorting (FACS) was used to get the basal immunology proﬁle of the rats.
Blood was collected at the same time as the haematology samples above into a 1.5 ml polypropylene tube
(Eppendorf Safe-Lock) pre-ﬁlled with 4 μl (20 units) heparin (Leo Pharma) and inverted immediately at
least 10 times and stored at 4 °C until used (1–10 h). The samples are identiﬁed as blood_-
basal_immunology in Supplementary Table 3.
Twenty microliter of blood was added in duplicate to 96 well v-bottom polypropylene plates (BD
Falcon), taking care to not include any coagulated samples. Up to ﬁve different ﬂuorescently labelled or
biotin-conjugated monoclonal antibodies (MAbs; see below) were diluted in FACS-buffer (Mg2+ and
Ca2+ free PBS-D [Life Technologies, Carlsbad, CA, USA] containing 1% bovine serum albumin [Sigma-
Aldrich], 2 mM Na2EDTA [Merck, Darmstadt, Germany] and 0,02% NaN3) to pre-determined optimal
concentrations and combined into a single tube. Antibody concentrations were considered optimal if
negative and positive populations were sufﬁciently separated or, for the measurement of mean
ﬂuorescence intensity, when the antibody had reached a saturating level. A corresponding volume of 2 μl
per antibody was added per well containing non-lysed whole blood. Aliquots from several samples were
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pooled and used for compensation set-up and ﬂuorescence minus one (FMO) controls. These controls
were added on a separate plate. Samples were mixed for 5 s by gentle vortexing, placed on ice in a
Styrofoam box, covered with aluminium foil and allowed to incubate for 20 min. After incubation, a total
volume of 300 μl FACS-buffer was added per well followed by centrifugation at 485 × g for 3 min (4 °C).
The supernatant was discarded and ﬂuorochrome-conjugated streptavidin was added at 2 μl per well,
followed by incubation for 15 min on ice. Without further washing, 220 μl of a hypertonic buffer
containing 8.29 g NH4Cl (Sigma-Aldrich), 1.0 g KHCO3 (Sigma-Aldrich) and 37.2 mg Na2EDTA
(Merck), pH 7.2 per dm3 was added per well. Samples were allowed to incubate at room temperature for
10 min or until lysis was complete in all wells. After centrifugation, samples were washed once in
hypertonic buffer and thereafter incubated for 15 min in 220 μl of 0.5% (w/v) phosphate-buffered
formaldehyde solution (Sigma-Aldrich) at room temperature, taking care to mix the cells thoroughly
before the incubation. Remaining ﬁxative was removed by washing the cells twice in FACS-buffer. Stained
cells were kept for up to six days in FACS-buffer in the dark until analysed. Duplicate samples were
pooled before acquisition, which was performed on a four-colour BD FACS Calibur for the ﬁrst four
batches and thereafter on a BD SORP LSR-II Analytic Flow Cytometer. The data was analysed with
FlowJo (Tree Star Inc., Ashland, OR).
Antibodies used for ﬂow cytometry: The following MAbs were purchased from BD Pharmingen (San
Diego, CA): CD45 (OX-1 FITC), RT1-B (OX-6 PE), CD45RA (OX-33 Pe-Cy5), CD45RC (OX22-PE),
αβTCR (R73 biotin and PerCP/APC), CD8a (OX-8 FITC), CD25 (OX-39 PE/APC), CD4 (OX-35 APC/
Pe-Cy5), CD28 (JJ319 FITC), pan-MHC class I (OX-18 PE), pan-granulocyte (HIS-48 biotin/Fitc).
Streptavidine (SA)-APC was used as a secondary reagent. Cell surface expression of a molecule (e.g.,
CD25) was measured as the mean ﬂuorescence intensity (MFI) of the corresponding staining. The subset
of cells with highest expression was identiﬁed as ‘high’ (e.g., CD25highCD4) and their frequency in a
particular population of cells was calculated as percent of the parent population (e.g., CD4 T cells).
Subsets of white blood cells (WBCs) were determined by multiplying the proportion of that particular
subset (e.g., B cells) with the total CD45+ population (CD45 is ubiquitously expressed on all WBCs). The
concentration of WBCs in the blood was then determined using a hemocytometer (basal hematology
measure). This assay is identiﬁed by the method FACS in Supplementary Table 2.
Experimental Autoimmune Encephalomyelitis (EAE)
EAE was induced by injecting myelin oligodendrocyte protein emulsiﬁed with Freund’s adjuvant
subcutaneously at the base of the tail. This injection was performed immediately before tipping the tail of
the rats to collect blood for basal immunology and basal hematology. Therefore, those measures should
not be affected by the injection. The rats were then scored daily as follows: 0= healthy; 1= tail weakness
or tail paralysis; 2= hind leg paresis or hemiparesis; 3= hind leg paralysis or hemiparalysis; 4= tetraplegy,
urinary, and/or fecal incontinence; and 5= death. If severe disease (score 4) was observed for two
consecutive days, the rats were sacriﬁced for ethical reasons. The daily scores are not provided as part of
this Data Descriptor, but measures capturing the severity of EAE are provided so that an effect of the
disease on the other phenotypes can be tested. These measures are: whether the rat died of EAE (possibly
sacriﬁced for ethical reasons), maximum score between injection and sacriﬁce, and score at sacriﬁce.
Euthanasia and tissue dissection
Unfasted rats were euthanized between 10am and 4pm by exsanguination under isoﬂuorane anesthesia
(O2 ﬂow (2 L/min) with 3–5% isoﬂuorane). Blood was obtained by cardiac puncture, then the heart was
dissected out, weighed and snap-frozen. Thereafter the punched ear, abdominal aorta, liver and bones
were dissected in parallel whenever possible. Treatment of the ear, aorta and bones are detailed in the
following subsections. Liver samples were snap-frozen. Other tissues (thymus, brain, pituitary, spinal
cord, spleen, kidneys, adrenal glands, tail) were collected and snap-frozen for future studies, but no data
are submitted as part of this Data Descriptor from these samples.
Serum biochemistry
Blood was collected by a heart puncture in the left ventricle with a 23-gauge needle. Blood was kept at
room temperature for 4 h, then at 4 °C for 4–12 h until it was centrifuged at 2000 rpm for 20 min. The
serum was separated, aliquoted and stored at −80 °C. The samples are identiﬁed as serum in
Supplementary Table 3.
Serum was analysed on a fully automated Olympus AU400 chemistry Immuno Analyser at the MRC
Harwell laboratory. This assay is identiﬁed by the method Biochemical analysis in Supplementary Table 2.
Arterial elastic lamina ruptures
The spontaneous rupture of the internal elastic lamina (IEL) in various arteries occurs to different extents
in different rat strains. In the Brown Norway rat, large numbers occur in the abdominal aorta (AA)
and common iliac arteries (IA) and so this rat strain is a model of large artery elastic lamellar defects,
and thus indirectly, of interest for studying factors affecting aneurysm formation. We have quantiﬁed
this phenomenon in the AA and in the left IA (LIA) in 1002 of the HS rats, from generation
5 to generation 8. To do this, the AA and the proximal 1 cm of the LIA were dissected out, rapidly rinsed
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in saline and ﬁxed by immersion in buffered formalin. The samples are identiﬁed as aorta in
Supplementary Table 3.
‘En face’ preparations of the unperfused AA and the attached LIA were then made. Under a dissecting
microscope, arteries were cleaned, opened longitudinally and pinned out, luminal surface uppermost. The
luminal surface was stained ﬁrst with acid orcein (1% orcein in 100mls of 70% ethanol,+0.6 mls of fuming
HCl. Staining time 15min.) and after washing, with Groat’s hematoxylin (1 g ferric ammonium sulfate
dissolved in 50ml distilled water+0.8ml fuming H2SO4 mixed with 50ml of 1% solution of hematoxylin
in 95% ethanol. Staining time around 5min.) to show the internal elastic lamina (IEL) and the nuclei
respectively. Stains were applied drop by drop to the surface of the preparation so as not to stain the
underside. After staining, arteries were dehydrated, unpinned, cleared and mounted on slides for
microscopic observation. With this technique, as previously described21, ruptures appear as dark grey
transverse bands due to absence of the internal elastic lamina, which stains pink, and the intense staining
of underlying smooth muscle cell nuclei, which are not stained in areas where the IEL is present. Ruptures
were then quantiﬁed at a ﬁnal magniﬁcation of x 40. For each individual, the total number of IEL ruptures
in the AA and LIA were recorded and each rupture was graded on a semi-quantitative scale according to
its size in the circumferential direction, using a grid in the eyepiece. A ﬁnal score was calculated taking into
account the size of the ruptures. Thus the degree of IEL rupture in each AA and LIA was expressed as a
number of ruptures per artery, or as a score indicating the severity of the phenomenon. For each rat, global
values were also obtained by adding those for AA and LIA. This assay is identiﬁed by the method Staining
and observation under the microscope in Supplementary Table 2.
Bone mass and strength
At dissection, the bones were kept on ice until stored at −20 °C. The samples are identiﬁed as bones in
Supplementary Table 3.
For bone density and structure, femurs were placed in plastic tubes ﬁlled with 70% ethyl alcohol and
centered in the gantry of a Norland Stratec XCT Research SA+pQCT (Stratec Electronics, Pforzheim,
Germany). Slice measurements of 0.26 mm thickness and a voxel size of 0.07 mm were taken at the
midshaft, distal femur and perpendicularly through the femoral neck. For each slice, the X-ray source was
rotated through 180° of projection. Volumetric BMD (vBMD; mg/cm3), cross sectional area (CSA; mm2)
and polar moment of inertia (Ip; mm4) were measured from the pQCT images. Density thresholds of 500
and 900 were used to identify mineralized bone. The femur BMC (g) was measured using DXA (PIXImus
mouse densitometer, Lunar Corp., WI, USA). The femoral neck width (NW; mm) was measured in the
anterior-posterior direction using digital calipers. For bone biomechanics, femurs were tested in three-
point bending by positioning them on the lower supports of a three-point bending ﬁxture and applying
load at the midpoint using a material testing machine (Alliance RT/5, MTS Systems Corp., Eden Prairie,
USA). Force and displacement measurements were collected every 0.05 s. From the force versus
displacement curves, work to failure (W; in mJ) was calculated in TestWorks software. This assay is
identiﬁed by the method Bone analysis in Supplementary Table 2.
Wound healing
The ear punch model was used to measure wound healing22. At 7 weeks of age a 2-mm hole was made in
the centre of the cartilaginous part of one ear using a metal ear punch (Fine science tools, model:
24210/02). At the end of the experiment, the whole ear was cut out with scissor and placed in 1.5 ml 10%
buffered formalin. The samples are identiﬁed as ear in Supplementary Table 3.
To calculate the area of the hole, the ear was ﬁrst trimmed and blotted dry with some tissue so that it
could be placed ﬂat between two slides (we used VWR 72 Polysine or Superfrost with dimensions
25 × 75 × 1 mm), and scanned (48-bit colour, 4800 dpi). The hole was delimited and the area calculated
using the software ImageJ. The scale was set by using the straight line tool across the side of the slide
(25 mm) and ticking the ‘Global’ box, then the hole area was measured by using the free line drawing
tool around the hole in the ear. This assay is identiﬁed by the method Image analysis in Supplementary
Table 2.
DNA extraction and genotyping
Approximately 50 mg of liver tissue (dissected from the outbred rats and kindly provided by Dr Myrna
Mandel, NIH, for the eight progenitors) was subjected to DNA extraction using a classical Phenol/
chlorofrom method (Sambrook, Fritsch, Maniatis) with a subsequent RNAse A digest. DNA was resolved
in low EDTA buffer (10 mM Tris 0,1 mM EDTA pH 8.0) to a ﬁnal concentration of 50 ng/μl. DNA
extraction for all samples was performed at the Max-Delbrück Center for Molecular Medicine, MDC,
Berlin, Germany.
Genotyping was carried out using a custom Affymetrix array (RATDIV array; see supplementary note
in ref. 4 for more information on the array). Brieﬂy, the array interrogates 805,399 SNPs chosen based on
partial sequence data available for 14 rat strains, three of which are amongst the HS founder strains
(Brown Norway BN, Fischer F344 and Wistar Kyoto WKY). Work by the STAR consortium had shown
that variation segregating between these 14 strains is representative of that in most other laboratory
strains23, so it was expected that the RATDIV array would be appropriate for genotyping the
Heterogeneous Stock.
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Genotyping was performed according to the Affymetrix SNP chip 6.0 protocol using 250 ng
genomic DNA for StyI and NspI, respectively. Genotyping was performed either at the MDC or at the
Centre National de Genotypage (CNG), Evry, France. This information is included in the metadata
submitted to ArrayExpress (Data Citation 1). 15 samples were genotyped at both centres (Supplementary
Table 4).
Genotype calling
Genotypes were called from the CEL ﬁles using Affymetrix Power Tools (APT) version 1.14.2, and its
BRLMM-P algorithm24. This algorithm uses information from all the CEL ﬁles as well as priors on the
position and scatter of the clusters used to call genotypes. All the CEL ﬁles reported in this Descriptor
were analysed together, as well as with a number of other inbred and outbred rats so as to improve the
quality of the calls.
















Positioning the RATDIV SNPs on the Rnor5.0 assembly
The sequences targeted by the probes on the array were mapped to the latest reference genome (Rnor5.0)
using BLAST25 and requiring an exact match of all 33 nucleotides to the plus or minus strand.
Selection of a subset of high quality SNPs for haplotype reconstruction
A subset of 262,052 high-quality, informative markers were selected to reconstruct the genome of each
HS rat as a mosaic of the founder genomes. This was motivated by the need for high-quality progenitor
genotypes in order to ensure accurate haplotype reconstruction. We now list the ﬁlters used to select
those markers. First, we kept only markers for which the RATDIV target sequence mapped perfectly and
uniquely to Rnor5.0 (761,333 markers left). We excluded those SNPs that were within 13 bp of an indel
(754,843 left). To apply the next ﬁlters, we used the reference sequence (BN) in place of the sequence and
genotypes of the BN progenitor. This decision was made because the quality of the DNA available from
that progenitor was poor. However, we only observed 2,892 genotype differences between the reference
sequence and the sequence of the BN progenitor generated by us. We went on to exclude those SNPs for
which the array-based or the sequence-based genotype of any of the progenitors was heterozygous or
missing; we also excluded markers which were monomorphic across the 8 progenitors (490,147 markers
left); we ﬁltered out SNPs with a call rate lower than 0.99 (0.95 for markers on the X chromosome), those
giving rise to 4 or more mendelian inconsistencies (calculated using the genotyped of 100 parents of HS
rats, data not reported here), as well as those with fewer than 9 homozygous calls of each type (AA and
BB) and 3 heterozygous calls. Also excluded were those markers with a ‘heterozygous offset’ lower than
-0.05 or a Fisher linear discriminant value lower than 6 (as recommended by Affymetrix technical
support, personal communication). Figure 3a illustrates a good quality SNP and one of poor quality.
262,052 markers passed all the ﬁlters. The average spacing between these SNPs is 12.5 kb. These SNPs are
high-quality and informative, and were used to reconstruct the progenitor haplotypes in the HS rats using
the software HAPPY.
Of these, 222,655 were used for the analysis reported in ref. 4, where SNP selection was based on
alignment of the RATDIV probes and sequence data to Rnor3.4.
Haplotype reconstruction in the outbred rats
The methods used to generate haplotype dosages (derived data) are detailed in ref. 4. Brieﬂy, we used the
R HAPPY package7 (www.well.ox.ac.uk/happy) to calculate descent probabilities from the 8 progenitors
for each outbred rats at each of 262,052 inter-marker intervals and then averaged these probabilities over
90-kb windows, such that we eventually worked with 24,616 probability matrices.
Whole genome shotgun sequencing of the eight progenitors
We generated DNA libraries from genomic DNA samples of the original rats that were used to create
the Heterogeneous Stock (progenitors). The libraries were generated using standard protocols
www.nature.com/sdata/
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(Life Technologies) and had a median insert size of between 109 and 196 bp. All libraries were sequenced
with fragment (50 bp) and paired-end (50+35 bp) runs using the next-generation sequencing (NGS)
platform SOLiD 4 and SOLiD 5500 sequencers to a depth of at least 22x base coverage for each of the
eight HS progenitors.
Sequence alignment
The sequencing reads were mapped to the rat reference assembly Rnor3.4 using BWA26 v0.5.9 with
parameters -c –l 25 –k 2 –n 10. They were aligned against the Rnor5.0 assembly using BWA 0.5.10
software with default parameters; the pairing of paired-reads was done using ‘sample’ option of BWA.
Alignments from different libraries of the same HS progenitor were combined into a single BAM ﬁle
(Supplementary Table 5).
Variant calling
Variant calling was performed independently for each progenitor. SNPs and short insertions and
deletions (indels) were called using different pipelines for the reads mapped to the Rnor3.4 assembly and
those mapped to Rnor5.0. We start by presenting the former.
SNPs and short indels (o10 bp) were called using a modiﬁed Samtools27 pipeline: only
unambiguously mapped reads were used to prevent false-positive that can be scored between paralogous
sequences. Sites with coverage below 4 or over 2000 mostly represent NGS-inaccessible and repetitive
sequences that are collapsed in genome reference, respectively, and were excluded from SNP/indel calling.
Read bases with base-quality below 30 were considered unreliable and, thus, ignored during variant
calling. Duplicate reads starting at the same position and mapped to the same strand as another read were
discarded as likely PCR artefacts. Each of the called alleles had to be supported by at least one read where
the variant mapped within the seed part of the read (ﬁrst 25 bases). Non-reference alleles called with
fewer than 3 reads were treated as missing genotypes. Variable sites with more than 2 alleles within one
founder were set to missing. We considered the remaining variants to be homozygous non-reference
alleles (frequency of non-reference call>2/3) or heterozygous alleles (frequency between 1/3 and 2/3).
Calling of SNPs and short indels based on alignments to Rnor5.0 was performed using GATK toolkit28
. Only polymorphisms with scores 50 and above, with homozygous and different alleles (polymorphic
among HS progenitor rats) were used. Prediction of the functional effect of each variant was performed
by Variant Effect Predictor tool VEP 2.1 tool29.
We called copy number variants on both assemblies by using depth-of-coverage approach
implemented in DWAC-Seq v. 0.56 (https://github.com/Vityay/DWAC-Seq) using default parameters.
Structural variants (SVs) were called using discordant pair mapping implemented in 1-2-3-SV v. 1.0
(https://github.com/Vityay/1-2-3-SV), requiring unambiguous mapping of both paired tags and at least 4
tag pairs per SV event. SV calls from these tools were merged.
False positive and false negative rates
The BAC and next-generation sequencing data for the LE/Stm discussed in the following paragraph are
not included in this descriptor but are publicly available (see ref. 4).
Figure 3. Genotyping quality control. (a) Genotyping samples shown in the hybridization signal space
(A −B; (A+B/2)) used by BRLMM-P for calling genotypes. A and B are the raw hybridization signals in the
CEL ﬁles. Each dot represents a sample. Homozygote calls are coloured in red and yellow, heterozygote
calls in orange and uncalled samples in blue. Only markers showing three large, well-resolved clusters with
few uncalled samples were selected for haplotype reconstruction. (b) Principal component analysis (PCA) of
the genotype calls. Each dot is a sample. The position of the samples on the ﬁrst two principal components.
Those samples genotyped at CNG are coloured in blue, those genotyped at the MDC in red. The genotypes
were encoded as 0,1,2 for this analysis, missing values were replaced by the minor allele frequency of the
SNP, and the PCA was carried out without centering or scaling the genotypes.
www.nature.com/sdata/
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The genome of the LE/Stm strain was sequenced on the SOLiD platform in the same way as the NIH-
HS strains and analysed using the same bioinformatics pipeline (that for assembly Rnor3.4). Thirteen
BACs from that same strain were sequenced using capillary methods, assembled and manually edited,
producing a total of 2.1 Mb ﬁnished sequence. False positive and false negative rates were estimated from
1.9Mb of genome sequence syntenic between BACs and genome assembly, excluding low quality BAC
sequence (as deﬁned by the BAC ﬁnishing team) and inaccessible regions (as deﬁned above). False
positive and false negative rates within this 1.9 Mb were estimated from the discordance between the BAC
and NGS allele calls.
The false positive rate was independently investigated by PCR-based resequencing of a subset of
variants chosen at random among those segregating between the HS progenitors. 96 SNPs and 96 indels
were checked. Oligonucleotide primers were selected to amplify 300 bp fragments around the candidate
polymorphism. When ampliﬁcation was successful (SNPs: 84, indels: 80), amplicons were sequenced on
an Applied Biosystems ABI 3730XL sequencer using Big-Dye terminator and analysed with Polyphred
software manually.
184 copy number variants and structural variants were selected. PCR primers were designed so that
the presence or absence (depending on the variation type) of a PCR product could conﬁrm the presence
of the variation. After PCR, samples were run on agarose gel and analysed manually. Of the 184
amplicons, 93 gave a PCR product in at least one of the progenitors.
The false positive and negative rates are presented in Table 2 and discussed in the technical validation
section.
Deﬁnition of NGS-accessible genome
In order to estimate the missing portion of variation that we failed to access with current NGS sequencing
technology, we evaluated effective genome coverage of our NGS data. We deﬁned inaccessible regions of
the HS rat genomes as was done for mouse genomes30. A base was considered as accessible if it did not
overlap simple, tandem repeats or low complexity sequence (deﬁned by Dust, source: Ensembl release 66;
http://www.ensembl.org), was not covered by more than 150 reads, and average mapping quality was at
least 40. Nucleotide positions within 15 bp of indels were also considered as inaccessible for SNP calling.
Data Records
The Rat Genome Sequencing and Mapping Consortium generated the data.
Data record 1
Phenotypes of the HS rats, and experimental covariates. measures.txt is a tab-delimited text ﬁle with
values for 195 phenotypes and 21 covariates that may affect the phenotypic measurements, for a total of
2,006 outbred rats. All phenotypes and covariates are described in Supplementary Table 1. Missing values
are encoded as NA. measures.txt was submitted as supplementary ﬁle to ArrayExpress (Data Citation 1)
as well as ﬁgshare (Data Citation 2).
Data record 2
Genotypes of the HS rats and the progenitors of the Stock. The genotypes ﬁle is a tab-delimited text ﬁle
with genotypes for 1,407 outbred rats, 15 of which were genotyped twice (once in each genotyping centre,
MDC and CNG, see Methods), as well as the eight progenitors. It includes genotypes for all 805,399
markers on the RATDIV array. Genotypes are encoded as 0 (reference homozygote), 1 (heterozygote),
2 (non-reference homozygote). Missing values are encoded as NA. The genotypes ﬁle E-MTAB-2332.
processed.1.zip is available from the processed ﬁle download link in ArrayExpress experiment accession
E-MTAB-2332 (Data Citation 1).
Data record 3
List of high-quality markers. markers_selected_for_Rn50.txt is a tab-delimited text ﬁle listing the 262,052
markers selected for haplotype reconstruction based. Each marker is identiﬁed by its RATDIV ID
(‘Rn34_’), which refers to its initial position on Rnor3.4. The position of the marker on Rnor5.0 is
indicated. This ﬁle was submitted as a supplementary ﬁle to ArrayExpress (Data Citation 1).
Call type True positives False positives (FPR) False negatives (FNR)
SNPs 2290 63 (2.7%) 475 (17.2%)
Indels 178 4 (2.2%) 126 (41.4%)
Structural variants 10 2 (16.7%) 19 (65.5%)
Table 2. Comparison of variants calls from NGS and Sanger sequencing.
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Data record 4
Haplotype dosages for the HS rats. haplotype_dosages_Rnor50.tar.gz was obtained by reconstructing the
genome of each HS rat as a mosaic of the progenitor genomes using the piece of software HAPPY7. The
reconstruction is based on the markers listed in markers_selected_for_Rn50.txt. The ﬁle corresponds to
HAPPY’s so called genome cache, a collection of R objects (‘.RData’) that are best utilised with the R
HAPPY package (see www.well.ox.ac.uk/happy). The genome cache contains the probabilities to be
descended from each of the eight progenitors (haplotype dosages), for each HS rat and at each locus in the
genome. Haplotype dosages are available for an additive and a full model7. At a given locus, the
probabilities are presented in an N x s matrix, where N is the number of HS rats (1,407+15 rats that were
genotyped twice) and s is the number of progenitors (8) for the additive model, and the number of unique
pairs of progenitors (32) for the full model. The IDs of the columns are stored in the strains.RData object,
the IDs of the rows in the subjects.RData object. Each matrix is an R object called by the name of the
marker at the leftmost position of the interval4,7 (there are only 24,616 matrices in the genome cache
because the haplotype dosages were averaged over 90 kb windows as explained in ref. 4). The HS rats are
identiﬁed by the name of the corresponding CEL ﬁle in the genome cache (i.e., in subjects.RData). The
correspondence with the IDs used throughout the other data reported in this Descriptor is available from
Supplementary Table 4 and from the metadata submitted to ArrayExpress (Data Citation 1), as is the
‘duplicate’ status of each rat. haplotype_dosages_Rnor50.tar.gz was submitted to ﬁgshare (Data Citation 2).
Data record 5
Sequence variants for the progenitors. HS_SNPs_Rn34.txt.gz, HS_Indels_Rn34.txt.gz, HS_SVs_Rn34.txt.
gz, HS_SNPs_Indels_Rn50.txt.gz and HSLE_SVs_Rn50.txt.gz are tab-delimited text ﬁles containing the
SNPs, indels, and structural variants (SVs) called for each of the eight progenitors (plus the rat strain
Long Evans (LE) for HSLE_SVs_Rn50.txt.gz). The assembly against which the sequencing reads were
aligned for variant calling is indicated in the name of the ﬁle. Missing values are encoded as N in the
SNPs and indels related ﬁles, while only positive calls are made for the structural variants (SVs). In
HS_SVs_Rn34.txt.gz and HSLE_SVs_Rn50.txt.gz, a deletion is annotated as Deletion(RD), a duplication
as Duplication(RD), an inversion as Inverted_pair(RP), a tandem duplication as Everted_pair(RP) and a
deletion Distant_tags(RP), where RD refers to a method for calling variants based on read depth, and RP
a method based on orientation and spacing of read pairs (see methods). For those variants called by the
RP method, the number of read pairs supporting the call in indicated in brackets for each progenitor. For
variants called with the RD method, the ratio between the number of reads in the progenitor and the
number of reads in a reference (BN/Mcwi ‘Eve’ rat sequence) is indicated for each progenitor. Those
variants supported by at least 4 pairs (RP) or with copy number change greater than 25% were included
in the ﬁle.
All ﬁles were submitted as supplementary ﬁles to ArrayExpress (Data Citation 1).
Data record 6
Accessible genome. *_genome_accessibility_Rn34.bed.gz and *_genome_accessibility_Rn50.bed.gz where
* takes values in {ACI, BN, BUF, F344, M520, MR, WKY, WN} are bed ﬁles with the intervals deemed
accessible for next –generation sequencing. They were calculated for both assemblies as indicated in the
name of the ﬁle. All ﬁles were submitted as supplementary ﬁles to ArrayExpress (Data Citation 1).
Data record 7
Progenitor SNPs and indels reformatted in an R object suitable for merge analysis. merge_factors.RData
is an R object which when loaded into an R session is a list with two components: 1) a data.frame with
position, genotypes for all SNPs and indels called on Rnor5.0 for the eight progenitors, and
corresponding strain distribution pattern (i.e., an indication of which progenitors share the same allele)
and 2) a list with as many unique elements as unique strain distribution patterns, and each element a
matrix by which the appropriate matrix of haplotype dosages should be multiplied for merge analysis
(see refs 4,8 for more information on the merge analysis). merge_factors.RData was submitted to ﬁgshare
(Data Citation 2).
Data record 8
Haplotype dosages and imputed genotypes at all sequence variants for the HS rats. The ﬁle HS.hdf5 is an
HDF5 ﬁle (http://www.hdfgroup.org/HDF5/) containing two elements: 1) additive haplotype dosages
stored in an 1,422 × 8 × 24,616 array and 2) imputed genotypes for 1,422 observation (1,407 rats+15
duplicates) at 543,4692 SNPs and indels. Information about the rats, the variants, etc. is also stored in the
HDF5 ﬁle, which was submitted as supplementary ﬁles to ArrayExpress (Data Citation 1).
Technical Validation
Comparison of variants calls from NGS and Sanger sequencing to estimate the false positive
and false negative rates, and conﬁrmation by PCR-based re-sequencing
False positive and negative rates were estimated by sequencing 2.1 Mb of LE/Stm BAC libraries by both
the next generation sequencing (NGS) pipeline used for the HS progenitors and Sanger sequencing (gold
standard). Table 2 shows rather high false negative rates but small false positive rates.
www.nature.com/sdata/
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The low false positive rates were conﬁrmed by PCR-resequencing. All of the 84 SNPs and 80 indels for
which ampliﬁcation was successful were conﬁrmed. Of the 93 structural variants (SVs) that gave a PCR
product, a group of 39 variants that were predicted SVs in the NIH-HS founders, were also conﬁrmed by
PCR in the reference substrain BN/NHsdMcwi, indicating that these are probably assembly errors in the
reference genome Rnor3.4. Of the remaining 54 variants, 53 gave a banding pattern in agreement with the
NGS calls.
Concordance between technical duplicates and principal component analysis (PCA) to
investigate whether samples genotyped at one centre are different from samples genotyped
at the other centre
15 HS rats were genotyped at both centres (CNG and MDC) following DNA extraction at MDC. Using
the subset of 262,052 high-quality SNPs, we investigated the concordance between these technical
replicates. The average concordance across the 15 duplicates is 0.997, showing that the genotypes were
used for subsequent analyses are very reliable.
A PCA was carried out using the genotypes at all SNPs on the RATDIV array. Figure 3b shows that
there is no batch effect attributable to the genotyping centre.
Usage Notes
Our recent publication4 illustrates how our data can be used and we refer the reader to it for more
information on how we analysed our data and interpreted the results.
Figure 2b brieﬂy recapitulates which data are combined for genetic mapping, and merge analysis.
A brief usage note on how to perform merge analysis is provided in Supplementary Information 1.
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